Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dustin J Maly

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
International Journal of Antimicrobial Agents|July 25, 2020
Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in miceNicoleta Anghel, Pablo A Winzer, Dennis Imhof, et al.
Journal of Medicinal Chemistry|February 11, 2012
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activitySteven M Johnson, Ryan C Murphy, Jennifer A Geiger, et al.
The Journal of Infectious Diseases|December 8, 2016
Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for CryptosporidiosisDeborah A Schaefer, Dana P Betzer, Kylie D Smith, et al.
The Journal of Infectious Diseases|November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against ToxoplasmosisMatthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Nature Structural & Molecular Biology|May 4, 2010
Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitorsKayode K Ojo, Eric T Larson, Katelyn R Keyloun, et al.
European Journal of Medicinal Chemistry|February 18, 2014
Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoesRama Subba Rao Vidadala, Kayode K Ojo, Steven M Johnson, et al.
The Journal of Clinical Investigation|May 9, 2012
Transmission of malaria to mosquitoes blocked by bumped kinase inhibitorsKayode K Ojo, Claudia Pfander, Natascha R Mueller, et al.
The Journal of Infectious Diseases|October 15, 2013
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validationKayode K Ojo, Richard T Eastman, Ramasubbarao Vidadala, et al.
The Journal of Infectious Diseases|March 23, 2017
Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyMatthew A Hulverson, Sumiti Vinayak, Ryan Choi, et al.
ACS Medicinal Chemistry Letters|February 5, 2014
Potent and selective inhibitors of CDPK1 from <i>T. gondii</i> and <i>C. parvum</i> based on a 5-aminopyrazole-4-carboxamide scaffoldZhongsheng Zhang, Kayode K Ojo, Ramasubbarao Vidadala, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
International Journal of Antimicrobial Agents|July 25, 2020
Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in miceNicoleta Anghel, Pablo A Winzer, Dennis Imhof, et al.
Journal of Medicinal Chemistry|February 11, 2012
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activitySteven M Johnson, Ryan C Murphy, Jennifer A Geiger, et al.
The Journal of Infectious Diseases|December 8, 2016
Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for CryptosporidiosisDeborah A Schaefer, Dana P Betzer, Kylie D Smith, et al.
The Journal of Infectious Diseases|November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against ToxoplasmosisMatthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Nature Structural & Molecular Biology|May 4, 2010
Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitorsKayode K Ojo, Eric T Larson, Katelyn R Keyloun, et al.
European Journal of Medicinal Chemistry|February 18, 2014
Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoesRama Subba Rao Vidadala, Kayode K Ojo, Steven M Johnson, et al.
The Journal of Clinical Investigation|May 9, 2012
Transmission of malaria to mosquitoes blocked by bumped kinase inhibitorsKayode K Ojo, Claudia Pfander, Natascha R Mueller, et al.
The Journal of Infectious Diseases|October 15, 2013
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validationKayode K Ojo, Richard T Eastman, Ramasubbarao Vidadala, et al.
The Journal of Infectious Diseases|March 23, 2017
Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyMatthew A Hulverson, Sumiti Vinayak, Ryan Choi, et al.
ACS Medicinal Chemistry Letters|February 5, 2014
Potent and selective inhibitors of CDPK1 from <i>T. gondii</i> and <i>C. parvum</i> based on a 5-aminopyrazole-4-carboxamide scaffoldZhongsheng Zhang, Kayode K Ojo, Ramasubbarao Vidadala, et al.
Pageof 13